Quality Control News and Research

RSS

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant, is providing an update regarding its efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization of Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

11 Jan 2011

VCU Massey Cancer Center introduces safer, more effective form of radiation therapy

Virginia Commonwealth University Massey Cancer Center has introduced a safer and more effective form of radiation therapy to treat cancer. The Center now offers volumetric modulated arc therapy (VMAT) delivery using the Philips Pinnacle3 SmartArc software to provide radiation treatment for multiple tumor sites, including prostate, head and neck, brain, breast and lung. VCU Massey is the first cancer center in the Richmond area to offer this cutting-edge radiation technique.

10 Jan 2011

Sudan referendum approaches, highlighting health, development challenges facing the south

"Southern Sudan is scheduled to start voting on January 9 on whether to become an independent country or remain part of Sudan, Africa's largest nation which has been wracked by decades of conflict," CNN reports (Wilkinson, 1/5).

6 Jan 2011

AvMed receives NCQA's Excellent Accreditation status for commercial and Medicare products

Once again, AvMed Health Plans has received an Excellent Accreditation status from the National Committee for Quality Assurance (NCQA) for both its commercial and Medicare products, a distinction shared only by a select group of health plans in the country.

5 Jan 2011

Aceto closes transaction for acquisition of Rising's assets

Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced that it has closed the previously announced transaction for its wholly-owned subsidiary to acquire certain assets of Rising Pharmaceuticals, Inc ("Rising").

3 Jan 2011

Crothall partners with 3M to implement effective infection control

Crothall Healthcare, a premier provider of support services to healthcare clients, announced its Preferred Partnership arrangement with 3M to kick-off its powerfully enhanced approach to infection control.

29 Dec 2010

Exiqon announces introduction of GLP compliant services for miRNA biomarker screening

Exiqon A/S, a leading provider of technologies for biomarker detection, today announced the introduction of GLP compliant services for miRNA biomarker screening and diagnostic assay development for clinical trials.

27 Dec 2010

Scientist discovers molecular switch controlling synthesis of ribosomes

A scientist from the Florida campus of The Scripps Research Institute has discovered a molecular switch that controls the synthesis of ribosomes. Ribosomes are the large machineries inside all living cells that produce proteins, the basic working units of any cell. These new findings offer a novel target for potential treatments for a range of diseases, including cancer.

23 Dec 2010

Mesa Labs announces acquisition of Apex's biological indicators business

Mesa Laboratories, Inc., a Lakewood, Colorado based manufacturer of electronic instruments and disposables today announced the acquisition of the biological indicators business of Apex Laboratories, Inc., a North Carolina based company. The acquisition of the Apex business is expected to be immediately accretive to Mesa's earnings per share.

22 Dec 2010

NAFC forms council to establish independent quality standards for incontinence products

The National Association For Continence (NAFC) is heading a newly formed council with the objective of establishing national, independent quality standards for disposable adult absorbent products provided by states to Medicaid waiver recipients cared for in their private homes rather than as residents of a state-funded nursing home.

20 Dec 2010

MOCON board declares quarterly cash dividend of $0.095 per share

MOCON, Inc. announced today that on December 16, 2010, its Board of Directors declared a quarterly cash dividend of nine and one-half cents ($0.095) per share, payable on February 18, 2011, to shareholders of record on February 4, 2011.

17 Dec 2010

Mayo clinic creates new computerized radiation tracking system

Mayo Clinic is initiating a new imaging exam tracking system that, among other things, enables a comprehensive view of a patient's radiation exposures over time.

13 Dec 2010

FDA grants Neoprobe Type B pre-IND meeting for RIGS technology BLA

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.

10 Dec 2010

MyHospital website goes live

The public will have access to nationally-consistent performance data for almost 1,000 Australian hospitals online for the first time at the federal government’s MyHospitals website. The website includes information on 922 public and private hospitals around the country and is live at 11am (AEDT) on Friday.

9 Dec 2010

e-cigarettes spark debate in U.S.

Electronic cigarettes have been seen as a tobacco product but not as drugs. The US Food and Drug Administration had appealed to the court to treat these cigarettes as drugs but the court says this is an oversight. The FDA cited five e-cigarette distributors for poor manufacturing practices and falsely claiming that the products help people stop smoking.

8 Dec 2010

Financial Times contrasts 'bottom up' and 'top down' approaches to developing country drugs

The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.

8 Dec 2010

Concentrated nicotine in E-cigarattes poses unknown risks to consumers

What do some pesticides and "electronic cigarettes" have in common? According to a new report published in the American Journal of Public Health, the answer is unregulated concentrations of nicotine that may pose unknown risks to consumers who are exposed to them.

8 Dec 2010

Electronic cigarettes are potentially harmful, researchers say

Electronic cigarettes (or e-cigarettes), also called "electronic nicotine delivery systems," are increasingly used worldwide even though only sparse information is available on their health effects. In the United States, e-cigarettes are readily available in shopping malls in most states and on the Internet.

4 Dec 2010

Prostate cancer imaging shows real-time tumor metabolism

A UCSF research collaboration with GE Healthcare has produced the first results in humans of a new technology that promises to rapidly assess the presence and aggressiveness of prostate tumors in real time, by imaging the tumor's metabolism.

3 Dec 2010

Expert panel at RSNA meeting to discuss medical imaging technique

An expert panel convened today at the annual meeting of the Radiological Society of North America (RSNA) to discuss medical imaging appropriateness, ionizing radiation from imaging procedures and efforts under way to curb overutilization, decrease radiation dose and educate patients on the risks and benefits of medical imaging.

2 Dec 2010

Quality Control News and Research

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

VCU Massey Cancer Center introduces safer, more effective form of radiation therapy

Sudan referendum approaches, highlighting health, development challenges facing the south

AvMed receives NCQA's Excellent Accreditation status for commercial and Medicare products

Aceto closes transaction for acquisition of Rising's assets

Crothall partners with 3M to implement effective infection control

Exiqon announces introduction of GLP compliant services for miRNA biomarker screening

Scientist discovers molecular switch controlling synthesis of ribosomes

Mesa Labs announces acquisition of Apex's biological indicators business

NAFC forms council to establish independent quality standards for incontinence products

MOCON board declares quarterly cash dividend of $0.095 per share

Mayo clinic creates new computerized radiation tracking system

FDA grants Neoprobe Type B pre-IND meeting for RIGS technology BLA

MyHospital website goes live

e-cigarettes spark debate in U.S.

Financial Times contrasts 'bottom up' and 'top down' approaches to developing country drugs

Concentrated nicotine in E-cigarattes poses unknown risks to consumers

Electronic cigarettes are potentially harmful, researchers say

Prostate cancer imaging shows real-time tumor metabolism

Expert panel at RSNA meeting to discuss medical imaging technique

eBook: Comprehensive quality control solutions for biologics manufacturing eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News